Showing results (61-70 of 108) with videos related to
Sort By:
Pageof 11
Cancers|January 9, 2021
Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma CellsRebaz Ahmed, Ranganayaki Muralidharan, Akhil Srivastava, et al.Nanotechnology|August 27, 2013
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapyLuís F F Neves, John J Krais, Brent D Van Rite, et al.Scientific Reports|November 9, 2017
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapyAnish Babu, Narsireddy Amreddy, Ranganayaki Muralidharan, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|November 21, 2017
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatmentNarsireddy Amreddy, Anish Babu, Janani Panneerselvam, et al.Molecular Cancer Therapeutics|June 3, 2017
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuRRanganayaki Muralidharan, Anish Babu, Narsireddy Amreddy, et al.Oncotarget|May 27, 2015
Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activityJanani Panneerselvam, Manish Shanker, Jiankang Jin, et al.Journal of Biomedical Nanotechnology|June 21, 2016
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of CancerAkhil Srivastava, Anish Babu, Justyna Filant, et al.Oncology Reports|March 6, 2017
Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagyJames Griffith, Daniel Andrade, Meghna Mehta, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograftSatoshi Inoue, Amanda Hartman, Cynthia D Branch, et al.Cancer Letters|May 23, 2020
Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugsMahendran Chinnappan, Akhil Srivastava, Narsireddy Amreddy, et al.Pageof 11